BATTELLE MEMORIAL INSTITUTE - KALER TO - VIRAL GENE THERAPY FOR MENKES DISEASE

PIID: 75N95024F00003

Signed Date: Feb 25, 2026Effective Date: Sep 30, 2024End Date: Closes in 337 days

Award $

$3.1M

Vendor

BATTELLE MEMORIAL INSTITUTE

NAICS

541714

Signed Date

Feb 25, 2026

Key Details

Dollars Obligated

$3.1M

Base & All Options

$3.0M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

BETHESDA, MD, 208920003, CD-MD-08

Description

KALER TO - VIRAL GENE THERAPY FOR MENKES DISEASE

Context & Analysis

On Feb 25, 2026, Department of Health and Human Services obligated $3,109,431 to BATTELLE MEMORIAL INSTITUTE for kaler to - viral gene therapy for menkes disease. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. Performance is located in BETHESDA, MD. The contract is scheduled through Sep 29, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.